Search

everythinglearnresearchcommunity

for

Search:↓

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

Higher ischemia-modified albumin levels are linked to acne severity.

Higher levels of molybdenum and lead in hair are linked to increased cholesterol and dyslipidemia risk.

Women with PCOS have higher body fat and worse insulin resistance and lipid profiles.

Lipedematous alopecia causes permanent hair loss due to increased scalp fat.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Hair loss might be linked to eye aging due to inflammation markers in blood.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Androgenetic alopecia is linked to higher cholesterol in both sexes and obesity in women.

Hair loss may indicate higher risk of heart disease.

Certain genes and high cholesterol levels increase heart disease risk in Ethiopian patients with high blood pressure.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Rodent models of PCOS show some similar and some different lipid changes compared to humans.

PCOS has three subtypes, with 11-oxygenated androgens increasing metabolic risk.

Lipedematous alopecia involves a thickened scalp and hair loss, with limited effective treatments available.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

The rs1128977 gene variant may affect cholesterol and body measurements.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.